# Phase II Multicentric Study of Digoxin Per os in Classic or Endemic Kaposi' s Sarcoma

> **NCT02212639** · PHASE2 · UNKNOWN · sponsor: **Assistance Publique - Hôpitaux de Paris** · enrollment: 17 (estimated)

## Conditions studied

- Kaposi' s Sarcoma
- Classic Kaposi' s Sarcoma
- Endemic Kaposi' s Sarcoma
- Lymph Angio Proliferations

## Interventions

- **DRUG:** digoxin

## Key facts

- **NCT ID:** NCT02212639
- **Lead sponsor:** Assistance Publique - Hôpitaux de Paris
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2014-09
- **Primary completion:** 2019-01
- **Final completion:** 2019-09
- **Target enrollment:** 17 (ESTIMATED)
- **Last updated:** 2018-07-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02212639

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02212639, "Phase II Multicentric Study of Digoxin Per os in Classic or Endemic Kaposi' s Sarcoma". Retrieved via AI Analytics 2026-09-21 from https://api.ai-analytics.org/clinical/NCT02212639. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*